MedPath

Cresemba

Brand Name: Cresemba

Generic Name: Isavuconazonium Sulfate

Active
Registration Number

DR-XY47831

Dosage Form

Lyophilized Powder for Concentrate for Solution for I.V. Infusion

Issuance Date

March 30, 2022

Expiry Date

March 30, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength372.6 mg (equivalent to 200 mg Isa vuconazole)
Packaging10 mL-capacity Type I clear and colorless glass vial with butyl rubber teflon-coated stopper and aluminum seal with blue plastic flip-off cap (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antifungal
A
Application
Monitored Release
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Isavuconazonium SulfateActive
Monograph: Isavuconazonium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform